Diffusion MRI signal cumulants and hepatocyte microstructure at fixed diffusion time: Insights from simulations, 9.4T imaging, and histology

por Grussu, Francesco, Bernatowicz, Kinga, Casanova‐Salas, Irene, Castro, Natalia, Nuciforo, Paolo, Mateo, Joaquin, Barba, Ignasi, Perez‐Lopez, Raquel
Publicado 2022

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer

por Casanova-Salas, Irene, Masiá, Esther, Armiñán, Ana, Calatrava, Ana, Mancarella, Caterina, Rubio-Briones, José, Scotlandi, Katia, Vicent, Maria Jesús, López-Guerrero, José Antonio
Publicado 2015

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status

por Mancarella, Caterina, Casanova-Salas, Irene, Calatrava, Ana, García-Flores, Maria, Garofalo, Cecilia, Grilli, Andrea, Rubio-Briones, José, Scotlandi, Katia, López-Guerrero, José Antonio
Publicado 2017

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents

por Mancarella, Caterina, Casanova-Salas, Irene, Calatrava, Ana, Ventura, Selena, Garofalo, Cecilia, Rubio-Briones, José, Magistroni, Vera, Manara, Maria Cristina, López-Guerrero, José Antonio, Scotlandi, Katia
Publicado 2015

Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies

por Zurita, Amado J., Graf, Ryon P., Villacampa, Guillermo, Raskina, Kira, Sokol, Ethan, Jin, Dexter, Antonarakis, Emmanuel S., Li, Gerald, Huang, Richard S. P., Casanova-Salas, Irene, Vivancos, Ana, Carles, Joan, Ross, Jeffrey S., Schrock, Alexa B., Oxnard, Geoffrey R., Mateo, Joaquin
Publicado 2022

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy

por Rubio-Briones, Jose, Borque, Angel, Esteban, Luis M., Casanova, Juan, Fernandez-Serra, Antonio, Rubio, Luis, Casanova-Salas, Irene, Sanz, Gerardo, Domínguez-Escrig, Jose, Collado, Argimiro, Gómez-Ferrer, Alvaro, Iborra, Inmaculada, Ramírez-Backhaus, Miguel, Martínez, Francisco, Calatrava, Ana, Lopez-Guerrero, Jose A.
Publicado 2015

The PHLPP2 phosphatase is a druggable driver of prostate cancer progression

por Nowak, Dawid G., Katsenelson, Ksenya Cohen, Watrud, Kaitlin E., Chen, Muhan, Mathew, Grinu, D’Andrea, Vincent D., Lee, Matthew F., Swamynathan, Manojit Mosur, Casanova-Salas, Irene, Jibilian, Megan C., Buckholtz, Caroline L., Ambrico, Alexandra J., Pan, Chun-Hao, Wilkinson, John E., Newton, Alexandra C., Trotman, Lloyd C.
Publicado 2019